ADOREXT · FAB122-CT-2201

Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.

An open-label, multicenter extension study investigating the long-term safety of FAB122 in patients with amyotrophic lateral sclerosis.

Sponsor: Julius Clinical

Phase: III

Area: Neuromuscular disorders